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Cytosine methylation is the major covalent modifica-
tion ofmammalian genomicDNA andplays important
roles in transcriptional regulation. The molecular
mechanism underlying the enzymatic removal of
this epigenetic mark, however, remains elusive.
Here, we show that 5-methylcytosine (5mC) hydroxy-
lase TET1, by converting 5mCs to 5-hydroxymethyl-
cytosines (5hmCs), promotes DNA demethylation in
mammalian cells through a process that requires
thebase excision repair pathway. Though expression
of the12knownhumanDNAglycosylases individually
did not enhance removal of 5hmCs in mammalian
cells, demethylation of both exogenously introduced
andendogenous 5hmCs is promoted by theAID (acti-
vation-induced deaminase)/APOBEC (apolipopro-
tein B mRNA-editing enzyme complex) family of cyti-
dine deaminases. Furthermore, Tet1 and Apobec1
are involved in neuronal activity-induced, region-
specific, active DNA demethylation and subsequent
gene expression in the dentate gyrus of the adult
mouse brain in vivo. Our study suggests a TET1-
induced oxidation-deamination mechanism for
active DNA demethylation in mammals.INTRODUCTION
The mammalian genome is methylated predominantly at the C5
position of cytosine bases within CpG dinucleotides (Suzuki and
Bird, 2008; Zhu, 2009), whereas non-CpG methylation has been
observed at relatively low levels in pluripotent stem cells (Lister
et al., 2009; Ramsahoye et al., 2000). 5mCs, especially when
clustered, are important transcriptional silencers at gene
promoters and endogenous retrotransposons in the genome
(Jaenisch and Bird, 2003). DNA methylation also plays critical
roles in tissue-specific gene expression, X chromosome inacti-
vation, gene imprinting, and nuclear reprogramming (Bonasioet al., 2010; Feng et al., 2010b). Cytosine methylation is cata-
lyzed by a family of DNA methyltransferases (DNMTs), and defi-
ciencies in these enzymes result in profound developmental
defects (Goll and Bestor, 2005; Reik, 2007).
During early development, the mammalian DNA methylome is
dramatically reprogrammed at two stages (Feng et al., 2010b;
Gehring et al., 2009). In the zygote, DNA methylation of the
paternal, but not maternal, pronucleus is rapidly lost at the
genome-wide scale (Mayer et al., 2000; Oswald et al., 2000;
Surani et al., 2007). In primordial germ cells, DNA methylomes
undergo a second wave of reprogramming, resulting in a large
decrease in the global 5mC level (Hajkova et al., 2010; Surani
et al., 2007). In contrast, postdevelopmental DNA demethylation
occurs in a highly locus-specific fashion and has been shown to
regulate gene expression in various tissues (Ma et al., 2009a; Wu
and Zhang, 2010; Zhu, 2009). In addition, DNA demethylation is
required for epigenetic resetting during somatic reprogramming
by nuclear transfer (Simonsson and Gurdon, 2004), cell fusion
(Bhutani et al., 2010), or transcription factor-based derivation of
induced pluripotent stem cells (Mikkelsen et al., 2008). In the
adult mammalian brain, whereas the DNA epigenome is stable
at the genome-wide level (Ma et al., 2009b), emerging evidence
suggests the presence of active DNA modifications at specific
genomic loci, and thesemodifications are critical for certain types
of brain plasticity (Day and Sweatt, 2010; Ma et al., 2010). For
example, deletion of bothDnmt1 andDnmt3a leads to decreased
CpG methylation at several genomic loci and impacts synaptic
functions of adult forebrain neurons (Feng et al., 2010a). Deletion
of Gadd45b abolishes neuronal activity-induced DNA demethy-
lation in the adult mouse dentate gyrus at specific genomic loci,
including brain-derived neurotrophic factor (Bdnf) and fibroblast
growth factor 1 (Fgf1) promoters, andattenuates activity-induced
adult hippocampal neurogenesis (Ma et al., 2009b). Pharmaco-
logical inhibition of DNA methylation changes also affects
synaptic plasticity, learning, and memory (Day and Sweatt,
2010), further suggesting the importance of epigenetic DNA
modification mechanisms in the adult nervous system.
Although DNA demethylation in mammals has been observed
both at the genome-wide and locus-specific levels, mechanisms
underlying the removal of methyl groups from the genomic DNA
havebeenunder intensive debate (Ooi andBestor, 2008). SeveralCell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc. 423
mammalian proteins have been reported to exhibit DNA deme-
thylase activity; however, such activities remain controversial
(Wu and Zhang, 2010). Emerging evidence has implicated DNA
repair as a potential mechanism for active DNA demethylation
(Gehring et al., 2009; Ma et al., 2009a; Zhu, 2009). In plants,
a group of 5mC-specific DNA glycosylases, including ROS1,
DME, and DML2/3, can specifically excise 5mC to initiate the
base excision repair (BER) to achieve active DNA demethylation
(Zhu, 2009). However, no ortholog of these 5mC-specific DNA
glycosylases has been identified in mammalian genomes. Alter-
natively, it has been proposed that glycosylation of 5mC may
be preceded by deamination of 5mC and generation of a T:G
mismatch,whichcanbeefficiently repairedbymammalianglyco-
sylases TDGandMBD4 (Gehring et al., 2009;Morgan et al., 2004;
Rai et al., 2008). One cytidine deaminase, activation-induced
deaminase (AID), is required forOCT4 andNANOG promoter de-
methylation during in vitro nuclear reprogramming (Bhutani et al.,
2010). Aid null mice also exhibit significant defect in genome-
wide DNA demethylation in primordial germ cells (Popp et al.,
2010). However, AID is unable to act on double-stranded DNA
(dsDNA), and the 5mC reactivity for AID deamination in vitro is
much lower than unmethylated cytosines (Bransteitter et al.,
2003; Conticello et al., 2007; Di Noia and Neuberger, 2007; Lari-
jani et al., 2005), raising the question of whether AID, if it does
initiate demethylation, directly deaminates 5mCs in vivo.
TET proteins, a group of Fe(II)/2-oxoglutarate-dependent
dioxygenases, have recently been identified as 5mC hydroxy-
lases that oxidize 5mCs to produce 5hmCs (Ito et al., 2010;
Tahiliani et al., 2009). 5hmCmay achieve passive DNA demethy-
lation by excluding DNMT1, which maintains symmetric CpG
methylation during DNA replication (Valinluck and Sowers,
2007). Interestingly, Tet1 knockdown in mouse embryonic
stem cells (ESCs) results in Nanog promoter hypermethylation
and defects in ESC self-renewal (Ito et al., 2010). 5hmC has
also been hypothesized as a potential intermediate for active
DNA demethylation (Bonasio et al., 2010; Feng et al., 2010b;
Hajkova et al., 2010; Ito et al., 2010; Wu and Zhang, 2010;
Xu et al., 2011). However, direct evidence for active demethyla-
tion of 5hmC-containing DNA is lacking. In two recent studies,
loss-of-functionmutations of TET2 appeared to display opposite
effects on DNA methylation status (Figueroa et al., 2010;
Ko et al., 2010), further raising the question of a general role of
TET proteins and 5hmC in DNA demethylation. Notably,
5hmCs exist in relative abundance in various brain regions
(Kriaucionis and Heintz, 2009). The physiological function of
5hmC and TET proteins in the brain remains to be determined.
Here, we show that overexpression of TET1 in human cells re-
activates a methylation-silenced plasmid reporter and promotes
DNA demethylation of both exogenous nonreplicable methyl-
ated reporter plasmids and multiple endogenous genomic loci.
We provide direct evidence that human cells possess a robust
demethylating activity toward 5hmC-containing DNA, which is
DNA replication independent and requires an intact BER
pathway. Furthermore, AID/APOBEC cytidine deaminases
promote 5hmC demethylation both in cultured human cells and
in the adult mouse brain. Similar to deamination, 5hmCdemethy-
lation is processive, transcription dependent, and strand biased.
Finally, Tet1 is both sufficient and required for neuronal activity-424 Cell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc.induced, region-specific, and active DNA demethylation in the
adult mouse brain in vivo. Our study identified TET1 as a critical
factor to initiate an oxidation-deamination mechanism under-
lying active DNA demethylation in mammals.
RESULTS
TET1 Promotes DNA Demethylation in Human Cells
Wefirst confirmed the5mChydroxylaseactivityofhumanTET1by
analysisofpurifiedgenomicDNAfromHEK293cells overexpress-
ing the HA-tagged human TET1 catalytic domain (aa1418–2136,
referred toasTET1) using immunoblottingand immunocytochem-
istry (Figures 1A and Figure S1A available online). The specificity
of 5hmC antibodies was confirmed by immunoblotting of linear
DNA that contained almost exclusively unmethylated cytosines,
5mCs, or 5hmCs (Figure S1B). To examinewhether hydroxylation
of 5mC by TET1 promotes active DNA demethylation, we utilized
a reporter assay using an in vitro methylated GFP-expressing
plasmid (Figure S1C) (Ma et al., 2009b). Complete methylation
of all CpGs on the plasmid by the bacterial methyltransferase
SssI resulted in strong silencing of GFP expression after transfec-
tion into HEK293 cells (Figure 1A). Overexpression of TET1, but
not a catalytically inactive TET1 mutant (H1671Y/D1673A;
TET1m), promoted reactivation of GFP expression, resulting in
a significant increase in the number of GFP+ cells as quantified
by FACS (Figure 1A). Thus, TET1 hydroxylase activity promotes
the reversal of the silencing effect of cytosine methylation.
Cytosine methylation near transcription start sites (TSSs) of
genes is known to be critical for transcriptional silencing (Suzuki
and Bird, 2008). Bisulfite sequencing around the GFP TSS
showed very sparse CpG demethylation 48 hr after transfection
of SssI-methylated plasmids into HEK293 cells (Figure 1B).
Expression of TET1, but not TET1m, significantly enhanced the
demethylation of these CpGs (Figure 1B). As expected, sorted
GFP+ cells with TET1 expression displayed much increased
CpG demethylation (Figure 1B). We also used an independent
approach tomeasure CpGmethylation levels based on quantita-
tive PCR (qPCR) after HpaII digestion, which is blocked by both
CpG methylation and hydroxymethylation (Jin et al., 2010).
Quantitative analysis showed a significant increase of HpaII
sensitivity around GFP TSS in the presence of TET1, but not
TET1m (Figure 1C and Table S1). Because the reporter plasmid
is incapable of replication in HEK293 cells, the DNA demethyla-
tion observed around the GFP TSS is active in nature.
We next examined whether 5mC hydroxylation also promotes
demethylation of the endogenous genomic DNA. Indeed, over-
expression of TET1, but not TET1m, significantly increased HpaII
sensitivity at multiple loci from distinct genomic subregions (Fig-
ure 1C), including promoters of ribosomal DNA (rDNA), FGF1,
and neuroligin-3 (NLGN3), but not at long interspersed nonrepe-
titive elements (LINE-1s). Thus, TET1 overexpression also
promotes region-specific DNA demethylation at endogenous
genomic loci in human cells.
5hmC in Both CpG and CpH Contexts Can Be
Demethylated in Human Cells
To ascertain whether TET1-induced DNA demethylation is medi-
ated by 5hmC generation, we examined whether premodified
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Figure 1. TET1 Catalyzes 5mC Hydroxyl-
ation and Promotes Demethylation of Exog-
enous SssI-Methylated Reporter Plasmids
and Endogenous Genomic Loci
(A) Reactivation of methylation-silenced reporter
plasmids by TET1. Shown on the left are sample
images of immunostaining of HEK293 cells
cotransfected with SssI-methylated GFP expres-
sion plasmids and expression constructs for TET1
or TET1m. Scale bar, 10 mm. Shown on the right is
a summary of quantification of GFP+ cells as
measured by FACS. Values represent mean ±
SEM. n = 3; **p < 0.01; Student’s t test.
(B) Bisulfite sequencing analysis of reporter plas-
mids. Shown on the top is a schematic diagram of
the region around GFP transcription start site
(TSS) for bisulfite sequencing (indicated by the red
line). Shown on the left are illustrations of methyl-
ation status of CpGs within the sequenced region.
Black, methylated; yellow, unmethylated. Note the
much higher level of demethylation in GFP+-sorted
cells. Shown on the right is a summary of mean
numbers of CpGs that are demethylated within
each clone. Values represent mean ± SEM. n = 3;
*p < 0.05; Student’s t test.
(C) Effects of TET1 and TET1m overexpression on
the HpaII sensitivity of the GFP TSS region and
several endogenous genomic loci in HEK293 cells.
Open circles represent data from individual
experiments, and lines represent mean values.
**p < 0.01, *p < 0.05, and #p > 0.1; Student’s t test.
See also Figure S1 and Table S1.5hmC-containing DNA is demethylated in human cells. By
replacing deoxycytidine triphosphates (dCTPs) with either
5-methyl-deoxycytidine triphosphates (5mdCTPs) or 5-hydroxy-
methyl-deoxycytidine triphosphates (5hmdCTPs) in PCR reac-
tions, we generated linear GFP expression cassettes in which
almost all cytosines, except for primer regions, are either
5mCs or 5hmCs (99.3%of all cytosines; Figure 2A, Figure S2A,
and Table S1). As expected, HpaII can digest neither fully meth-
ylated nor fully hydroxymethylated DNA fragments (Figure S2B).
Overexpression of TET1, but not TET1m, led to significant HpaII
sensitivity near GFP TSS in 5mC-GFPDNA after transfection into
HEK293 cells (Figure 2B), which required demethylation of all
four cytosines in the CCGG motif. Importantly, HpaII sensitivity
at the same position arose on 5hmC-GFP DNA after transfection
and was not further increased by TET1 overexpression (Fig-
ure 2B). These results suggest that TET1-induced DNA deme-
thylation is a direct result of 5hmC generation in human cells.
To directly quantify cytosine demethylation, we carried out
bisulfite sequencing analysis of 5mC-GFP and 5hmC-GFP DNA
using a modified protocol (Table S1). Consistent with HpaII
digestion results, bisulfite sequencing of 5mC-GFPDNA showed
negligible demethylation after transfection into HEK293 cells
(Figures 2C and 2D). Expression of TET1 led to 0.8% of
5mCpGsdemethylated in each 500bp clone (Figure 2D). Surpris-
ingly, 5mCs in non-CpGcontexts (5mCpH,H=A/C/T) showed aneven higher frequency of demethylation in the presence of TET1
(Figure 2D). Importantly, robust demethylation occurred on
transfected 5hmC-GFP DNA, with 2% of 5hmCpGs and 9%
of 5hmCpHs demethylated in each clone, which accounts for
8.5% of all modified cytosines in this region (Figure 2D and Fig-
ure S2C). Collectively, these results demonstrate the presence of
a DNA replication-independent 5hmC-demethylating activity
and an unexpected capacity for active demethylation of 5hmCs
in non-CpG contexts in mammalian cells.
5hmC Demethylation Requires the BER Pathway
To characterize themechanism underlying 5hmCdemethylation,
we used pharmacological inhibitors to examine the potential
involvement of the BER pathway, which has been implicated
for DNA demethylation in vertebrates (Gehring et al., 2009; Ma
et al., 2009a). ABT-888 (ABT) inhibits poly(ADP-ribose) polymer-
ases (PARPs), which signals single-strand breaks (Donawho
et al., 2007; Purnell and Whish, 1980), whereas CRT0044876
(CRT) inhibits apurinic/apurimidinic endonuclease APE1 (Mad-
husudan et al., 2005). Both enzymes are critical components in
the BER pathway, and these two inhibitors block DNA demethy-
lation inmouse zygotes (Hajkova et al., 2010). Interestingly, HpaII
sensitivity aroundGFP TSS on 5hmC-GFPDNAwas abolished in
the presence of ABT and CRT (Figure 3A). Bisulfite sequencing
analysis further confirmed the reduced DNA demethylation ofCell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc. 425
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Figure 2. 5hmC-Containing DNA Is
Demethylated in HEK293 Cells
(A) A schematic diagram of a PCR-based
approach to generate 5mC- or 5hmC-containing
DNA fragments that contain an ubiquitin promoter
(pUbC) followed by the GFP open reading frame.
(B) Summary of CpG methylation levels of GFP
TSS regions under different conditions as quanti-
fied by HpaII sensitivity. Open circles represent
data from individual experiments, and lines
represent mean values. **p < 0.01, *p < 0.05, and
#p > 0.1; Student’s t test.
(C and D) Bisulfite sequencing analysis of 5mC-/
5hmC-GFP DNA fragments under different
conditions. Shown in (C) are sample traces from
bisulfite sequencing of 5hmC-GFP DNA before or
after transfection. Open and filled triangles indi-
cate cytosines in CpG and CpH contexts,
respectively. Arrows indicate demethylated
5hmCs. Shown in (D) are quantifications of de-
methylated CpGs (left) and CpHs (right) on 5mC-/
5hmC-GFP DNA. Values represent mean ± SEM.
n = 3; **p < 0.01, *p < 0.05, and #p > 0.1; Student’s
t test. See also Figure S2.5hmC-GFP DNA after treatment of these two inhibitors (Fig-
ure 3B). In addition, TET1-induced demethylation of endogenous
genomic loci, including FGF1 and rDNA promoters, was abol-
ished by ABT and CRT (Figure 3C). Neither of the inhibitors inter-
fered with the TET1 hydroxylase activity, as indicated by largely
unchanged overall 5hmC levels in HEK293 cells with TET1 over-
expression (Figure S3A). Taken together, these results suggest
that the BER pathway is required for demethylation of both exog-
enous 5hmC and endogenous loci after TET1 overexpression.
The central components of the BER pathway include DNA gly-
cosylases that recognize and remove specific types of damaged
or mismatched DNA bases (Wood et al., 2005). Overexpression
of each of the 12 known human DNA glycosylases in HEK293
cells (Figure S3B) did not lead to any noticeable decrease of
5hmC levels in the genomic DNA, as measured by immunoblot-
ting and immunocytochemistry (Figures S3C and S3D). Similarly,
no significant enhancement of demethylation of transfected
5hmC-GFP DNA was detected after overexpression of these426 Cell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc.glycosylases (Figure 3D). Thus, 5hmC
does not appear to be directly recognized
and removed by any of these glycosy-
lases under our experimental conditions.
AID/APOBEC Deaminases
Facilitate 5hmC Demethylation
Which pathway could process 5hmC in
mammalian cells? Previous studies have
suggested that coupling between the
AID/APOBEC family of cytidine deami-
nases and T:G mismatch glycosylases
maymediate DNA demethylation in verte-
brate cells (Morgan et al., 2004; Rai et al.,
2008). However, 5mCs appear to be less
favorable substrates than unmethylatedcytosines for AID in vitro (Bransteitter et al., 2003; Larijani
et al., 2005), suggesting that AID might not directly deaminate
5mCs during the process of active DNA demethylation. There-
fore, we examined whether the AID/APOBEC family of cytidine
deaminases might play a role in 5hmC demethylation. Interest-
ingly, AID overexpression led to a significant decrease of
5hmC levels induced by TET1 in HEK293 cells (Figures 4A and
4B and Figure S4A). Bisulfite sequencing analysis of transfected
5hmC-GFP DNA showed that AID significantly increased 5hmC
demethylation (Figure 4C). Importantly, these demethylated
cytosines were not unrepaired deamination products because
sequences of nonbisulfite-converted 5hmC-GFP DNA cotrans-
fected with AID showed no significant level of C-to-T transitions
(Figure S4C).
Does the demethylation-promoting effect of AID specifically
target 5hmCs or both 5hmCs and 5mCs? Overexpression of
AID showed no significant effect on the demethylation of 5mC-
GFP DNA (Figure 4C). Immunostaining also did not show any
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Figure 3. BER Enzyme Activities Are Required for 5hmC
Demethylation
(A and B) Effects of PARP1 inhibitor ABT-888 (50 mM) and APE inhibitor
CRT0044876 (50 mM) on demethylation of transfected 5hmC-GFP DNA frag-
ments. Shown in (A) is a summary of HpaII sensitivity assay. Open circles
represent data from individual experiments, and lines represent mean values.
*p < 0.05; Student’s t test. Shown in (B) is a summary of bisulfite sequencing
analysis. Values represent mean ± SEM. n = 3; *p < 0.05; Student’s t test.
(C) Effects of ABT and CRT on TET1-induced increases of HpaII sensitivity of
FGF1 (left) and rDNA (right) promoters. Open circles represent data from
individual experiments, and lines represent mean values. **p < 0.01, *p < 0.05,
and #p > 0.1; Student’s t test.
(D) Effects of overexpression of human DNA glycosylases on demethylation of
5hmC-GFP DNA fragments. Shown is a summary of bisulfite sequencing
analysis of 5hmC-GFPDNA after cotransfection with one of the 12 humanDNA
glycosylase cDNAs. Values represent mean ± SEM. n = 3; #p > 0.1; one-way
ANOVA.
See also Figure S3.noticeable change in genomic 5mC levels in AID-overexpressing
cells (Figure S4B). As expected, coexpression of AID and TET1
led to a significant increase in demethylation of 5mC-GFP DNA
(Figure 4C). Thus, AID appears to specifically promote 5hmCdemethylation but does not directly deaminate 5mCs to induce
demethylation.
We next examined whether other cytidine deaminases of the
AID/APOBEC family also promote demethylation of 5hmCs.
Overexpression of mouse Apobec1 (mApobec1), human
APOBEC2, APOBEC3A, 3C, and 3E, but not APOBEC3B or 3G,
significantly increased demethylation of 5hmC-GFP DNA after
transfection into HEK293 cells (Figure 4D and Figure S4D), sug-
gesting a general property of themajority of AID/APOBEC deam-
inases in promoting 5hmC demethylation. Notably, APOBEC1
and APOBEC2 have both been implicated in active DNA deme-
thylation in vertebrates (Morgan et al., 2004; Rai et al., 2008).
Deamination of 5hmC would produce 5-hydroxyluracil
(5hmU). Though there is no detectable endogenous 5hmU in
HEK293 cells, expression of TET1 resulted in a significant
amount of 5hmU (Figure 4E and Figure S4E). Direct transfection
of 5hmC-GFP DNA into HEK293 cells also led to a significant
amount of 5hmU, which was decreased by coexpression of
5hmU glycosylase SMUG1 (Boorstein et al., 2001)(Figure 4E).
In addition, overexpression of strong enhancers of 5hmC deme-
thylation, including mApobec1, APOBEC3A, and 3C, appeared
to produce higher levels of 5hmU (Figure S4F). Expression
analysis of HEK293 cells revealed the presence of many AID/
APOBEC deaminases and DNA glycosylases (Figure S4G and
Table S1), including known 5hmU glycosylases SMUG1, TDG
(Baker et al., 2002), NEIL1, and NTHL1 (Zhang et al., 2005).
Collectively, these results suggest the following model for
active DNA demethylation in mammalian cells (Figure 4F):
5mCs are first oxidized to 5hmCs by TET proteins. 5hmCs are
then deaminated by AID/APOBEC deaminases into 5hmU.
Finally, 5hmU can be excised by 5hmU glycosylases and
repaired by the BER pathway with unmethylated cytosines.
5hmC Demethylation Recapitulates Properties
of AID-Mediated Deamination
Much effort has beenmade to characterize catalytic properties of
AID, with a focus on the involvement of AID-mediated deamina-
tion in somatic hypermutation in B cells (Di Noia and Neuberger,
2007). If active 5hmC demethylation entails deamination, does it
exhibit known catalytic features of AID-mediated deamination?
First, AID-mediated deamination is a processive reaction
(Pham et al., 2003). Extensive bisulfite sequencing of 174 clones
of 5hmC-GFP DNA after transfection showed a broad distribu-
tion of numbers of demethylated 5hmCs in individual clones,
which significantly deviated from a distributive Poisson model
(p < 2 3 1026; Figure 5A). In three clones, 67%, 73%, and
86% of all 5hmCs on each clone were demethylated, indicating
high processivity of 5hmC demethylation.
Second, AID exhibits DNA sequence selectivity for deamina-
tionwith hot spots (WRCmotifs;W=A/T; R =A/G) and cold spots
(SYCmotifs; S=C/G;Y=C/T) (Phamet al., 2003). Tominimize the
nonspecific targeting effect of the processive activity, only single
demethylated 5hmCs at least 5 nucleotides away from any other
demethylated 5hmCswere analyzed. The observed frequency of
5hmC demethylation at WRC motifs was 2.4-fold higher than
that at SYC motifs (Figure 5B), indicating a similar sequence
preference between 5hmC demethylation and AID-mediated
deamination. Notably, the observed sequence preference ofCell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc. 427
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Figure 4. AID/APOBEC Deaminases Pro-
mote 5hmC Demethylation
(A and B) Overexpression of AID results in
a decrease in the abundance of 5hmCs in genomic
DNA samples from HEK293 cells as monitored by
immunoblotting (A) and ELISA (B) using anti-5hmC
antibodies.
(C) Effects of AID on demethylation of 5hmC-GFP
and 5mC-GFP DNA. Values represent mean ±
SEM. n = 3; *p < 0.05 and #p > 0.1; Student’s t test.
(D) Effects of overexpression of AID/APOBEC
deaminases on 5hmC demethylation as measured
by bisulfite sequencing. Values represent mean ±
SEM. n = 3; **p < 0.01 and *p < 0.05; Student’s t
test.
(E) Immunoblotting analysis of 5hmU levels in
HEK293 cells after TET1 expression or trans-
fection of 5hmC-GFP DNA, with or without the
expression of 5hmU glycosylase SMUG1.
(F) An oxidation-deamination-BERmodel of TET1-
induced active DNA demethylation in mammalian
cells.
See also Figure S4.5hmC demethylation is less robust than that of AID deamination
of unmethylated cytosines in vitro or in somatic hypermutation,
consistent with the notion that other AID/APOBEC deaminases
with different sequence selectivity may also contribute to 5hmC
demethylation.
Third, transcription has been shown to target AID to specific
genomic loci for deamination (Chaudhuri et al., 2003). We gener-
ated two variants of 5hmC-GFP DNA fragments, one with a trun-
cated UbC-promoter and one with no promoter (Figure S5A),
which exhibited either much reduced or no detectable GFP
expression after transfection (Figure S5B). Concomitantly, de-
methylation of these truncated 5hmC-GFP DNA fragments was
almost completely abolished (Figure 5C), suggesting that
sufficient transcriptional activity is a prerequisite for 5hmC
demethylation.
Finally, it has been shown that, on a transcribed dsDNA
substrate, AID preferentially deaminates the untranscribed428 Cell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc.strand (Chaudhuri et al., 2003). This
prompted us to discriminate demethyla-
tion of 5hmC-GFP DNA on two opposite
strands of DNA with bisulfite sequencing
analysis (Figure S5C). Indeed, the
average frequency of demethylation on
the untranscribed strand of 5hmC-GFP
DNA is 2.6-fold higher than that on the
transcribed strand at 48 hr after transfec-
tion (Figure 5D). This strand preference
was not due to an asymmetric distribution
of cytosines because it was observed in
both CpHs and symmetrically distributed
CpGs (Figure 5D).
Taken together, these results reveal
an unexpected similarity between two
seemingly unrelated processes—5hmC
demethylation andAID-mediated somatichypermutation—and further support the role of deamination in
active 5hmC demethylation.
TET1 and AID/APOBEC Deaminases Promote Region-
Specific DNA Demethylation in the Adult Mouse Brain
We next examined whether the TET1-induced oxidation-deami-
nationmechanism regulates active DNAdemethylation inmature
neurons of the adultmousebrain in vivo. Notably, 5hmChasbeen
shown tobe abundant in various adult brain regions, including the
hippocampal dentate gyrus (Mu¨nzel et al., 2010). We stereotaxi-
cally injected adeno-associated viruses (AAVs) overexpressing
TET1, or TET1m, into the adult mouse dentate gyrus and
measured 5hmC levels in microdissected dentate gyrus tissue
1 week after viral injection (Figure S6A). Despite the presence
of a high basal level of 5hmCs (1.35% of all cytosines), overex-
pression of TET1, but not TET1m, further increased the 5hmC
level by 43% (Figure 6A). On the other hand, AAV-mediated
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Figure 5. 5hmC Demethylation Recapitu-
lates Known Properties of AID-Catalyzed
Deamination
(A) A histogram of clone distribution of the
percentage of demethylated 5hmCs. A Poisson
distribution with l = 8.4% is shown as a black line.
Arrows indicate three highly processively deme-
thylated 5hmC-GFP clones. A small portion of the
reference sequence and the bisulfite sequencing
results for these three clones are shown in the
inset.
(B) Occurrence of single demethylated 5hmCs
at WRC and SYC motifs. WRC motif: W = A/T; R =
A/G. SYC motif: S = C/G; Y = C/T. Only deme-
thylated 5hmCs that are at least 5 nucleotides
away from any other demethylated 5hmCs are
analyzed. Values represent mean ± SEM. n = 3;
*p < 0.05; Student t test.
(C) Demethylation of promoter-truncated 5hmC-
GFP variants. The same region in the GFP open
reading frame is bisulfite sequenced for all vari-
ants. Values represent mean ± SEM. n = 3; **p <
0.01; Student t test.
(D) Demethylation of 5hmCs in the CpG (left) and
CpH (right) contexts on two opposite strands.
Demethylated 5hmCs of the forward (un-
transcribed) strand and the reverse (transcribed)
strand are represented by C-to-T and G-to-A
transitions in bisulfite sequencing (Figure S5C),
respectively. Values represent mean ± SEM. n = 3;
**p < 0.01; Student’s t test.
See also Figure S5.overexpression of AID significantly decreased the endogenous
level of 5hmCsby59% in theadult dentategyrus (Figure 6B), sup-
porting its role in 5hmC removal in vivo.
To determine whether TET1 and AID promote DNA demethy-
lation in the adult brain in vivo, we examined the CpGmethylation
status of promoter IX of Bdnf (Bdnf IX) and a brain-specific
promoter of Fgf1 (Fgf1B), two endogenous loci that have been
shown to exhibit neuronal activity-induced active DNA demethy-
lation in the adult dentate granule cells (Ma et al., 2009b). AAV-
mediated overexpression of TET1 or AID, but not TET1m, led
to significant decreases in the CpG methylation levels at these
two genomic loci in dentate neurons from multiple animals
(Figures 6C and 6D and Figures S6B and S6C). In contrast, the
CpG methylation status of a nonneuronal promoter of Fgf1
(Fgf1G) was not altered by these manipulations (Figure 6D and
Figure S6D). Consistent with our previous finding that the meth-
ylation status of Bdnf IX and Fgf1B promoters regulates their
gene expression (Ma et al., 2009b), both TET1- and AID-induced
demethylation was accompanied by a significant upregulation in
transcript levels of these two gene isoforms in vivo (Figure 6E).
Taken together, these results suggest that TET1 and AID are
sufficient to promote CpGdemethylation of specific endogenous
genomic loci and to increase expression of associated genes in
the adult mouse brain.Tet1 and Apobec1 Are Involved in Neuronal Activity-
Induced DNA Demethylation in the Adult Mouse Brain
Our previous studies have shown that synchronous activation
of adult dentate granule neurons in vivo by electroconvulsive
stimulation (ECS) leads to CpG demethylation of Bdnf IX and
Fgf1B promoters in these neurons within 4 hr but has no effect
on the Fgf1G promoter (Ma et al., 2009b). To assess whether
Tet1 is required for neuronal activity-induced DNA demethyla-
tion in vivo, we injected engineered AAVs that express short-
hairpin RNAs (shRNAs) to knock down the endogenous Tet1
expression in the adult dentate gyrus (Figure S7A). The two
shRNAs against mouse Tet1 have been previously character-
ized (Table S1) (Ito et al., 2010). We further confirmed the effec-
tiveness of these two shRNAs in knocking down endogenous
mouse Tet1 both in vitro and in vivo (Figure S7B). Interestingly,
expression of either shRNA against mouse Tet1, but not the
control shRNA, completely abolished ECS-induced demethyla-
tion of both Bdnf IX and Fgf1B, but not Fgf1G, promoters in
dentate neurons from multiple animals (Figures 7A–7C and
Figure S7E). ECS-induced expression of these two gene iso-
forms was also abolished (Figures 7D and 7E). Thus, endoge-
nous Tet1 is required for neuronal activity-induced, region-
specific, active DNA demethylation and gene expression in
the adult brain.Cell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc. 429
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Figure 6. TET1 and AID Regulate Endoge-
nous 5hmC Levels and Promote Region-
Specific DNA Demethylation in the Adult
Mouse Brain
(A and B) Effects of AAV-mediated overexpression
of control YFP, TET1, TET1m (A), and AID (B) on
the endogenous 5hmC levels as measured by
immunoblotting (left) and ELISA (right). Engineered
AAV viruses were stereotaxically injected into the
dentate gyrus of adult mice, and dentate gyrus
tissue was microdissected 1 week later for anal-
ysis. Values represent mean ± SEM. n = 3 animals
for each condition; **p < 0.01; Student’s t test.
(C and D) Effects of YFP, TET1, TET1m, and AID
overexpression on methylation levels of Bdnf IX
(C), Fgf1B, and Fgf1G (D) alternative promoters in
the adult dentate gyrus. Shown on top are
diagrams of promoters, and bars indicate regions
for bisulfite sequencing analysis. Values represent
mean ± SEM. n = 3 animals for each condition;
**p < 0.01 and *p < 0.05; Student’s t test.
(E) Effects of YFP, TET1, TET1m, and AID over-
expression on specific isoform and total expres-
sion levels of Fgf1 and Bdnf in the adult dentate
gyrus. Same groups of animals as in (C) and (D)
were examined. Values represent mean ± SEM.
**p < 0.01 and *p < 0.05; Student’s t test.
See also Figure S6.To directly examine whether 5hmCs can be demethylated in
neurons, we transfected 5hmC-GFPDNA fragments into primary
neurons in culture. Bisulfite sequencing analysis showed signif-
icant demethylation of 5hmC DNA in both CpG (5%) and
CpH (6%) contexts. Interestingly, the numbers of demethy-
lated 5hmCs in individual clones also exhibited a broad distribu-
tion, suggesting high processivity (Figure 7F).
To identify the endogenous deaminase that may contribute to
neuronal activity-induced DNA demethylation in vivo, we exam-
ined the expression of Aid/Apobec genes under normal condi-
tions and 4 hr after ECS in the adult dentate gyrus. Whereas
Aid, Apobec2, and Apobec4 appeared to be absent, Apobec1
and Apobec3 were expressed in the adult dentate gyrus at
similar levels with or without ECS (Figure S7C). We obtained
one shRNA (Ap1-5) that achieved effective knockdown of endog-
enous Apobec1 expression in culture and in the adult dentate
gyrus after AAV-mediated expression (Figure S7D and Table S1).
Interestingly, knockdown of Apobec1 significantly reduced ECS-430 Cell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc.induced demethylation of both Bdnf IX
and Fgf1B promoters in dentate neurons
from multiple animals in comparison to
those expressing the control shRNA
(Figures 7A–7C and Figure S7E). Further-
more, ECS-induced expression of these
two gene isoforms was completely abol-
ished (Figures 7D and 7E). It remains to
be determined whether Apobec3 also
plays a role in neuronal activity-induced
DNA demethylation and expression of
associated genes in the adult brain.Taken together, these results demonstrated that neurons
possess a significant capacity to demethylate 5hmCs and
suggest that Tet1/Apobec1-mediated oxidation-deamination
mechanism plays a critical role in neuronal activity-induced,
region-specific, active DNA demethylation in the adult mouse
brain.
DISCUSSION
Accumulating evidence supports the existence of activeDNAde-
methylation in vertebrate cells, yet the underlying molecular
mechanisms remain unclear (Wu and Zhang, 2010). The
discovery of the TET family of 5mC hydroxylases has raised the
question of its potential role in active DNA demethylation. Here,
we identify TET1-catalyzed 5mC hydroxylation as a key initiating
step in DNA excision repair-based active DNA demethylation in
mammalian cells both in vitro and in vivo. By introducing fully
modified linear dsDNA substrates with 5hmCs into HEK293 cells
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Figure 7. Tet1 and Apobec1 Are Involved in Neuronal Activity-Induced Region-Specific Demethylation in the Adult Mouse Brain
(A–C) Effects of AAV-mediated shRNA knockdown of endogenous Tet1 and Apobec1 on ECS-inducedCpGdemethylation ofBdnf IX (A), Fgf1B (B), and Fgf1G (C)
promoters. Engineered AAV viruses expressing control shRNA (CTL), two shRNAs against mouse Tet1 (Tet1-1 and Tet1-2), and one shRNA against mouse
Apobec1 (Ap1-5) were stereotaxically injected into the dentate gyrus of adult mice. One week after viral injection, animals were subjected to ECS or sham
treatment. Dentate gyrus tissue was microdissected 4 hr later for analysis. Values represent mean ± SEM. n = 3–6 animals for each condition; **p < 0.01 and
*p < 0.05; Student’s t test.
(D and E) Effects of Tet1 and Apobec1 knockdown on ECS-induced isoform-specific expression of Bdnf and Fgf1 in the adult dentate gyrus. Same groups
of animals as in (A–C) were examined. Values represent mean ± SEM. *p < 0.05; Student’s t test.
(F) Demethylation of 5hmC-GFP DNA fragments after transfection into primary hippocampal neurons in culture. Shown is a histogram of clone distribution of the
percentage of demethylated 5hmCs in 5hmC-GFP DNA fragments retrieved 7 days after transfection. A distributive Poissonmodel (l = 6.2%) is shown by a black
curve.
See also Figure S7.and primary mouse neurons, we demonstrate that mammalian
cells possess a robust, active demethylatingmachinery targeting
5hmC-containing DNA in both CpG and non-CpG contexts. We
further providemechanistic insights into this process by pharma-
cological inhibition of key DNA repair enzymes and genetic
manipulations of core enzymes in the BER pathway, including
DNA glycosylases and AID/APOBEC deaminases. In cultured
human cells, AID/APOBEC deaminases specifically promote
5hmC demethylation but have no apparent effect on 5mCs. In
the adult mouse brain, AID facilitates the removal of endogenous
5hmCs, and furthermore, both TET1 and AID promote region-
specific DNA demethylation in dentate neurons. Finally, loss-of-
function experiments establish an important role of endogenous
Tet1 and Apobec1 in neuronal activity-induced DNA demethyla-
tion and expression of associated genes in dentate neurons in the
adult mouse brain. Together, our results delineate a TET1/APO-
BEC-mediated oxidation-deamination mechanism underlying
active, region-specificDNAdemethylation inmammals. Previous
studies have implicated either 5hmC or deaminated 5mC as the
potential key intermediate for DNA demethylation. Our work
thus reconciles those previous studies and suggests a conver-
gence of two seemingly separate mechanisms into one singlecooperative pathway for BER-mediated completion of active
DNA demethylation.
Oxidation of 5mCs had been previously proposed to cause
passive DNA demethylation by preventing DNMT1 recognition
in vitro, which recognizes hemi-methylated CpGs after DNA repli-
cation to maintain a symmetric methylation pattern (Valinluck and
Sowers, 2007). We present evidence for an unequivocal role of
5mC hydroxylation in promoting DNA demethylation in a DNA
replication-independent manner by using nonreplicating SssI-
methylated plasmids and linear premodified dsDNA substrates.
Consistent with a role in active DNA demethylation, TET proteins
are expressed in mouse primordial germ cells (Hajkova et al.,
2010) and in the dentate gyrus of the adult mouse brain (Szwa-
gierczak et al., 2010), where genome-wide and locus-specific
DNA demethylation occur (Hajkova et al., 2010; Ma et al.,
2009b), respectively. The adult dentate gyrus provides a relative
homogenous population of postmitotic neurons in large numbers
(Ma et al., 2009b), which is particularly important for epigenetic
analysisbecauseeachdiploidcell displaysonly two locus-specific
binary modifications. Although mRNAs of all three Tet genes are
detected in the mouse hippocampus (Szwagierczak et al., 2010),
specific knockdown of Tet1 abolished neuronal activity-inducedCell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc. 431
promoter demethylation of Bdnf IX and Fgf1B, suggesting nonre-
dundant roles of different TET proteins in DNA demethylation. All
three TET proteins exhibit 5mC hydroxylase activity (Ito et al.,
2010), and it will be interesting to explore their roles in genome-
wideand region-specificDNAdemethylation indifferent cell types.
Previous studies (Hajkova et al., 2010; Rai et al., 2008) and our
current result support a role of BER in active DNA demethylation,
yet none of the known mammalian DNA glycosylases has been
shown to possess 5hmC glycosylase activity. Instead, our result
suggests that 5mCs, once converted to 5hmCs by TET proteins,
are processed by AID/APOBEC deaminases, a family of Zn2+-
dependent cytidine deaminases that have been implicated in
active DNA demethylation in vertebrates (Bhutani et al., 2010;
Conticello et al., 2007). AID appears to specifically promote de-
methylation of 5hmCs, but not 5mCs in mammalian cells. In
a recent study of reprogramming-associated demethylation of
OCT4 promoter, AID was shown to occupy its target loci even
before demethylation was initiated (Bhutani et al., 2010), sug-
gesting a preceding event to AID catalysis. In support of a role
of AID/APOBEC deaminases in TET1-induced DNA demethyla-
tion, 5hmC demethylation shares many known characteristics
of AID-induced deamination, including high processivity,
sequence selectivity, transcription dependency, and DNA strand
preference. Interestingly, the 5hmC demethylation-enhancing
ability is not limited to AID but is also present in multiple APOBEC
deaminases. Our results do not rule out the possibility that AID/
APOBEC deaminases may act on tertiary intermediates rather
than on 5hmCs directly, nor can we eliminate the possibility of
other pathways that process 5hmCs independently of AID/APO-
BEC deaminases in mammalian cells (Figure 4F). AID/APOBEC
deaminases are usually expressed in a highly restricted and
tissue-specific manner and exhibit distinct sequence selectivity
for deamination (Conticello et al., 2007); therefore, different
deaminases may mediate 5hmC demethylation cooperatively
with their individual sequence preferences. Previous in vitro anal-
ysis has revealed different capacities of AID/APOBEC family
members in deaminating unmethylated cytosines and 5mCs
(Conticello et al., 2007). Future studies of in vitro 5hmC deamina-
tion will provide critical insight into the role of AID/APOBEC
family members in DNA demethylation.
In summary, our results uncover a role for TET1, through
conversion of 5mC into a critical intermediate product 5hmC, in
promoting active DNA demethylation in mammalian cells both
in vitro and in vivo. In addition to a well-established association
with cancer (Jones and Baylin, 2002), accumulating evidence
implicates epigenetic aberrations inDNAmethylation in neurode-
generative diseases (Urdinguio et al., 2009) andpsychiatric disor-
ders (Feng and Fan, 2009). Identification of a role for TET1 and
5hmC in neuronal activity-induced DNA demethylation will
enhance our understanding ofmolecularmechanisms underlying
dynamic changesofDNAmethylation in theadult nervous system
and will provide therapeutic targets for novel treatments.EXPERIMENTAL PROCEDURES
DNA Constructs
Human open reading frame entry clones were either obtained from Johns
Hopkins HIT Center or cloned from a human cDNA library. Fully modified432 Cell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc.linear UbC-GFP fragments and promoter-truncated variants were generated
using dCTP, 5mdCTP (Amersham), or 5hmdCTP (Bioline) in PCR amplifica-
tions (Table S1C). AAV gene delivery vectors were constructed by cloning
the EF1a-Gene-WPRE and U6-shRNA-EF1a-EYFP-WPRE cassette (Ge
et al., 2006) into an AAV backbone. The efficacy of shRNAs against mouse
Tet1 and Apobec1 (Table S1E) were tested in cell culture after electropora-
tion and confirmed in adult mouse dentate gyri after AAV-mediated
expression.Methylated Reporter Assay and Quantitative Analysis
of DNA Methylation
NIT-GFPplasmidwasusedformethylationreporterassayaspreviouslydescribed
(Ma et al., 2009b). The methylation-sensitive restriction assay was carried out
using a StepOnePlus Real-Time PCR system (Applied Biosystems; Table S1A).
HpaII sensitivity of a CCGG site was calculated by [1  2Ct(mock)  Ct(HpaII)] 3
100%.Bisulfite (Zymo)-treatedDNAwasusedasa template forPCRamplification
of the region of interest as previously described (Table S1B) (Ma et al., 2008).
Primers targeting nonbisulfite converted sequences were used in bisulfite
sequencing analysis of 5hmC-GFP DNA fragments. Although these primers
do not selectively amplify either strand, demethylation of the forward (nontran-
scribed) strand would appear as C-to-T transitions in Sanger sequencing results,
whereas G-to-A transitions represent demethylation of the reverse (transcribed)
strand (Figure S5C).Detection andQuantification of 5hmCand 5hmUby Immunoblotting,
ELISA, and Immunocytochemistry
DNA samples were applied onto Hybond-N+ membrane (Amersham), cross-
linked by a UV stratalinker 1800 (Stratagene), and subjected to immunoblotting
using antibodies against 5hmC (Active motif; 1:10,000) or against 5hmU
(Abcam; 1:2000). For ELISA quantification of 5hmC, DNA standards and
samples were immobilized on a 96-well plate using Reacti-Bind DNA coating
solution (Thermo Scientific). Chemiluminescent signals were developed using
a TMB substrate (Thermo Scientific) and monitored by SpectraMax Plus 384
plate reader (Molecular Devices). Immunocytochemistry used the following
primary antibodies: anti-HA (rat; 1:500; Roche); anti-5hmC (rabbit; 1:500;
ActiveMotif); anti-5mC (mouse; 1:250; Eurogentec); and anti-V5 (goat; 1:500;
Abcam).Methylation and Gene Expression Analysis of the Adult Mouse
Dentate Gyrus
Adult mice (8- to 10-weeks-old, male, C57BL/6 background) were used for
analysis in accordance with protocols approved by the Institutional Animal
Care and Use Committee. High titers of engineered AAV2/9 were stereotaxi-
cally injected into the dentate gyrus of adult mice as previously described
(Ge et al., 2006). Mice were used 1 week after viral injection for analysis.
ECS was administered as previously described (Ma et al., 2009b). Sham
animals were similarly handled in parallel without the current delivery. Animals
were analyzed at 4 hr after ECS. DNA methylation and gene expression were
carried out as previously described (Tables S1B and S1D) (Ma et al., 2009b).SUPPLEMENTAL INFORMATION
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found with this article online at doi:10.1016/j.cell.2011.03.022.ACKNOWLEDGMENTS
We thank D.K. Ma and K. Christian for comments; members of Song and Ming
laboratories for discussion; Y. Gao for RNA-seq; H.C. Kang, J.S. Jeong, N.Y.
Jung and J. Shin for helpwithmolecular cloning; andQ. Hussaini, Y. Cai, and L.
Liu for technical support. This work was supported by AMRF and NIH
(HD069184 and NS048271) to G.-l.M., by NIH (NS047344, AG024984, and
MH087874) and NARSAD to H.J.S., and by fellowships from FARMS to
J.U.G, AMRF to Y.S., and MSCRF to C.Z.
Received: October 31, 2010
Revised: January 23, 2011
Accepted: March 11, 2011
Published online: April 14, 2011
REFERENCES
Baker, D., Liu, P., Burdzy, A., and Sowers, L.C. (2002). Characterization of the
substrate specificity of a human 5-hydroxymethyluracil glycosylase activity.
Chem. Res. Toxicol. 15, 33–39.
Bhutani, N., Brady, J.J., Damian, M., Sacco, A., Corbel, S.Y., and Blau, H.M.
(2010). Reprogramming towards pluripotency requires AID-dependent DNA
demethylation. Nature 463, 1042–1047.
Bonasio, R., Tu, S., and Reinberg, D. (2010). Molecular signals of epigenetic
states. Science 330, 612–616.
Boorstein, R.J., Cummings, A., Jr., Marenstein, D.R., Chan, M.K., Ma, Y.,
Neubert, T.A., Brown, S.M., and Teebor, G.W. (2001). Definitive identification
of mammalian 5-hydroxymethyluracil DNA N-glycosylase activity as
SMUG1. J. Biol. Chem. 276, 41991–41997.
Bransteitter, R., Pham, P., Scharff, M.D., and Goodman, M.F. (2003). Activa-
tion-induced cytidine deaminase deaminates deoxycytidine on single-
stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA
100, 4102–4107.
Chaudhuri, J., Tian, M., Khuong, C., Chua, K., Pinaud, E., and Alt, F.W. (2003).
Transcription-targeted DNA deamination by the AID antibody diversification
enzyme. Nature 422, 726–730.
Conticello, S.G., Langlois, M.A., Yang, Z., and Neuberger, M.S. (2007). DNA
deamination in immunity: AID in the context of its APOBEC relatives. Adv.
Immunol. 94, 37–73.
Day, J.J., and Sweatt, J.D. (2010). DNA methylation and memory formation.
Nat. Neurosci. 13, 1299–1440.
Di Noia, J.M., and Neuberger, M.S. (2007). Molecular mechanisms of antibody
somatic hypermutation. Annu. Rev. Biochem. 76, 1–22.
Donawho, C.K., Luo, Y., Luo, Y., Penning, T.D., Bauch, J.L., Bouska, J.J.,
Bontcheva-Diaz, V.D., Cox, B.F., DeWeese, T.L., Dillehay, L.E., et al. (2007).
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potenti-
ates DNA-damaging agents in preclinical tumor models. Clin. Cancer Res.
13, 2728–2737.
Feng, J., and Fan, G. (2009). The role of DNAmethylation in the central nervous
system and neuropsychiatric disorders. Int. Rev. Neurobiol. 89, 67–84.
Feng, J., Zhou, Y., Campbell, S.L., Le, T., Li, E., Sweatt, J.D., Silva, A.J., and
Fan, G. (2010a). Dnmt1 and Dnmt3a maintain DNA methylation and regulate
synaptic function in adult forebrain neurons. Nat. Neurosci. 13, 423–430.
Feng, S., Jacobsen, S.E., and Reik, W. (2010b). Epigenetic reprogramming
in plant and animal development. Science 330, 622–627.
Figueroa, M.E., Abdel-Wahab, O., Lu, C., Ward, P.S., Patel, J., Shih, A., Li, Y.,
Bhagwat, N., Vasanthakumar, A., Fernandez, H.F., et al. (2010). Leukemic
IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt
TET2 function, and impair hematopoietic differentiation. Cancer Cell 18,
553–567.
Ge, S., Goh, E.L., Sailor, K.A., Kitabatake, Y., Ming, G.L., and Song, H. (2006).
GABA regulates synaptic integration of newly generated neurons in the adult
brain. Nature 439, 589–593.
Gehring, M., Reik, W., and Henikoff, S. (2009). DNA demethylation by DNA
repair. Trends Genet. 25, 82–90.
Goll, M.G., and Bestor, T.H. (2005). Eukaryotic cytosine methyltransferases.
Annu. Rev. Biochem. 74, 481–514.
Hajkova, P., Jeffries, S.J., Lee, C., Miller, N., Jackson, S.P., and Surani, M.A.
(2010). Genome-wide reprogramming in the mouse germ line entails the
base excision repair pathway. Science 329, 78–82.
Ito, S., D’Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C., and Zhang, Y.
(2010). Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal
and inner cell mass specification. Nature 466, 1129–1133.Jaenisch, R., and Bird, A. (2003). Epigenetic regulation of gene expression:
how the genome integrates intrinsic and environmental signals. Nat. Genet.
Suppl. 33, 245–254.
Jin, S.G., Kadam, S., and Pfeifer, G.P. (2010). Examination of the specificity of
DNA methylation profiling techniques towards 5-methylcytosine and 5-hy-
droxymethylcytosine. Nucleic Acids Res. 38, e125.
Jones, P.A., and Baylin, S.B. (2002). The fundamental role of epigenetic events
in cancer. Nat. Rev. Genet. 3, 415–428.
Ko, M., Huang, Y., Jankowska, A.M., Pape, U.J., Tahiliani, M., Bandukwala,
H.S., An, J., Lamperti, E.D., Koh, K.P., Ganetzky, R., et al. (2010). Impaired
hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.
Nature 468, 839–843.
Kriaucionis, S., and Heintz, N. (2009). The nuclear DNA base 5-hydroxymethyl-
cytosine is present in Purkinje neurons and the brain. Science 324, 929–930.
Larijani, M., Frieder, D., Sonbuchner, T.M., Bransteitter, R., Goodman, M.F.,
Bouhassira, E.E., Scharff, M.D., and Martin, A. (2005). Methylation protects
cytidines from AID-mediated deamination. Mol. Immunol. 42, 599–604.
Lister, R., Pelizzola, M., Dowen, R.H., Hawkins, R.D., Hon, G., Tonti-Filippini,
J., Nery, J.R., Lee, L., Ye, Z., Ngo, Q.M., et al. (2009). Human DNAmethylomes
at base resolution show widespread epigenomic differences. Nature 462,
315–322.
Ma, D.K., Chiang, C.H., Ponnusamy, K., Ming, G.L., and Song, H. (2008). G9a
and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of
adult neural stem cells. Stem Cells 26, 2131–2141.
Ma, D.K., Guo, J.U., Ming, G.L., and Song, H. (2009a). DNA excision repair
proteins and Gadd45 as molecular players for active DNA demethylation.
Cell Cycle 8, 1526–1531.
Ma, D.K., Jang, M.H., Guo, J.U., Kitabatake, Y., Chang, M.L., Pow-Anpongkul,
N., Flavell, R.A., Lu, B., Ming, G.L., and Song, H. (2009b). Neuronal activity-
induced Gadd45b promotes epigenetic DNA demethylation and adult neuro-
genesis. Science 323, 1074–1077.
Ma, D.K., Marchetto, M.C., Guo, J.U., Ming, G.L., Gage, F.H., and Song, H.
(2010). Epigenetic choreographers of neurogenesis in the adult mammalian
brain. Nat. Neurosci. 13, 1338–1344.
Madhusudan, S., Smart, F., Shrimpton, P., Parsons, J.L., Gardiner, L., Houl-
brook, S., Talbot, D.C., Hammonds, T., Freemont, P.A., Sternberg, M.J.,
et al. (2005). Isolation of a small molecule inhibitor of DNA base excision repair.
Nucleic Acids Res. 33, 4711–4724.
Mayer, W., Niveleau, A., Walter, J., Fundele, R., and Haaf, T. (2000). Demethy-
lation of the zygotic paternal genome. Nature 403, 501–502.
Mikkelsen, T.S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P.,
Bernstein, B.E., Jaenisch, R., Lander, E.S., andMeissner, A. (2008). Dissecting
direct reprogramming through integrative genomic analysis. Nature 454,
49–55.
Morgan, H.D., Dean, W., Coker, H.A., Reik, W., and Petersen-Mahrt, S.K.
(2004). Activation-induced cytidine deaminase deaminates 5-methylcytosine
in DNA and is expressed in pluripotent tissues: implications for epigenetic
reprogramming. J. Biol. Chem. 279, 52353–52360.
Mu¨nzel, M., Globisch, D., Bru¨ckl, T., Wagner, M.,Welzmiller, V., Michalakis, S.,
Mu¨ller, M., Biel, M., and Carell, T. (2010). Quantification of the sixth DNA base
hydroxymethylcytosine in the brain. Angew. Chem. Int. Ed. Engl. 49, 5375–
5377.
Ooi, S.K., and Bestor, T.H. (2008). The colorful history of active DNA demethy-
lation. Cell 133, 1145–1148.
Oswald, J., Engemann, S., Lane, N., Mayer, W., Olek, A., Fundele, R., Dean,
W., Reik, W., and Walter, J. (2000). Active demethylation of the paternal
genome in the mouse zygote. Curr. Biol. 10, 475–478.
Pham, P., Bransteitter, R., Petruska, J., and Goodman, M.F. (2003). Proces-
sive AID-catalysed cytosine deamination on single-stranded DNA simulates
somatic hypermutation. Nature 424, 103–107.
Popp, C., Dean, W., Feng, S., Cokus, S.J., Andrews, S., Pellegrini, M., Jacob-
sen, S.E., and Reik, W. (2010). Genome-wide erasure of DNA methylation inCell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc. 433
mouse primordial germ cells is affected by AID deficiency. Nature 463, 1101–
1105.
Purnell, M.R., and Whish, W.J. (1980). Novel inhibitors of poly(ADP-ribose)
synthetase. Biochem. J. 185, 775–777.
Rai, K., Huggins, I.J., James, S.R., Karpf, A.R., Jones, D.A., and Cairns, B.R.
(2008). DNA demethylation in zebrafish involves the coupling of a deaminase,
a glycosylase, and gadd45. Cell 135, 1201–1212.
Ramsahoye, B.H., Biniszkiewicz, D., Lyko, F., Clark, V., Bird, A.P., and Jae-
nisch, R. (2000). Non-CpG methylation is prevalent in embryonic stem cells
and may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci.
USA 97, 5237–5242.
Reik, W. (2007). Stability and flexibility of epigenetic gene regulation in
mammalian development. Nature 447, 425–432.
Simonsson, S., and Gurdon, J. (2004). DNA demethylation is necessary for the
epigenetic reprogramming of somatic cell nuclei. Nat. Cell Biol. 6, 984–990.
Surani, M.A., Hayashi, K., and Hajkova, P. (2007). Genetic and epigenetic
regulators of pluripotency. Cell 128, 747–762.
Suzuki, M.M., and Bird, A. (2008). DNA methylation landscapes: provocative
insights from epigenomics. Nat. Rev. Genet. 9, 465–476.
Szwagierczak, A., Bultmann, S., Schmidt, C.S., Spada, F., and Leonhardt, H.
(2010). Sensitive enzymatic quantification of 5-hydroxymethylcytosine in
genomic DNA. Nucleic Acids Res. 38, e181.
Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y.,
Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L., and Rao, A. (2009). Conversion434 Cell 145, 423–434, April 29, 2011 ª2011 Elsevier Inc.of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL
partner TET1. Science 324, 930–935.
Urdinguio, R.G., Sanchez-Mut, J.V., and Esteller, M. (2009). Epigenetic mech-
anisms in neurological diseases: genes, syndromes, and therapies. Lancet
Neurol. 8, 1056–1072.
Valinluck, V., and Sowers, L.C. (2007). Endogenous cytosine damageproducts
alter the site selectivity of human DNA maintenance methyltransferase
DNMT1. Cancer Res. 67, 946–950.
Wood, R.D., Mitchell, M., and Lindahl, T. (2005). Human DNA repair genes,
2005. Mutat. Res. 577, 275–283.
Wu, S.C., and Zhang, Y. (2010). Active DNA demethylation: many roads lead
to Rome. Nat. Rev. Mol. Cell Biol. 11, 607–620.
Xu,W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.H., Ito, S., Yang, C., Wang,
P., Xiao, M.T., et al. (2011). Oncometabolite 2-hydroxyglutarate is a competi-
tive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19,
17–30.
Zhang, Q.M., Yonekura, S., Takao, M., Yasui, A., Sugiyama, H., and Yonei, S.
(2005). DNA glycosylase activities for thymine residues oxidized in the methyl
group are functions of the hNEIL1 and hNTH1 enzymes in human cells. DNA
Repair (Amst.) 4, 71–79.
Zhu, J.K. (2009). Active DNA demethylation mediated by DNA glycosylases.
Annu. Rev. Genet. 43, 143–166.
